From November 2019 to 2021, Mark Fettman, MD, a psychiatrist from Portland, Ore., allegedly knowingly conducted office-based opioid treatment without complying with state requirements, according to the report.
He allegedly operated his clinic two days a month and prescribed patients maximum legal dosages of buprenorphine, a Schedule III opioid. He accepted cash payments and money orders but did not accept insurance.
The charges include 137 counts of drug trafficking, nine counts of money laundering and one count of engaging in corrupt activity. Dr. Fettman’s arraignment is scheduled for May 1.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
